Drug
Sulfasalazine clinical trials
Also written Azulfidine.
- studies test it
- 37
- open now
- 9
- in phase 3
- 7
- first study started
- 2001
Keep track of what changes. Save the Sulfasalazine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
37 studies that test it; most in 2023 (5)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 3 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 10
- Phase 2
- 11
- Phase 3
- 7
- Phase 4
- 8
- No phase
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 29
Brigham and Women's Hospital (2) · University of Nebraska (2) · University of Alabama at Birmingham (2) · Cairo University (1) · University of Arizona (1) · Galapagos NV (1) · University of Illinois at Chicago (1) · Haukeland University Hospital (1)
Often tested with
Tested in the same studies.
Leflunomide (9) · Hydroxychloroquine (8) · Methotrexate (8) · Etanercept (8) · Adalimumab (5) · Certolizumab Pegol (4) · Infliximab (4) · Golimumab (3)
Studies
Open first, then newest update. How each study uses Sulfasalazine is read from its arms, and is right about nine times in ten.
Testing it · 37
- Study of ECC4703 With Sulfasalazine and PitavastatinRecruitingPhase 1EccogeneNCT07726368Written as Sulfasalazine
- The Effect of Sulfasalazine on CRH Levels in Pregnant WomenRecruitingPhase 2Rutgers, The State University of New JerseyNCT05703425Written as Sulfasalazine
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingPhase 2NYU Langone HealthNCT07138898Written as Sulfasalazine
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of ResponseRecruitingPhase 3University of NebraskaNCT03414502Written as Sulfasalazine
- Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line TreatmentRecruitingPhase 1/2Assistance Publique - Hôpitaux de ParisNCT05580861Written as Sulfasalazine
- Glutamate Inhibitors in GlioblastomaRecruitingPhase 1/2University of ZurichNCT05664464Written as Sulfasalazine
- A Prospective, Single Arm, Open Label, Proof of Concept Clinical Study of Sulfasalazine in the Treatment of Active Systemic Lupus ErythematosusNot yet recruitingPhase 2Qiong FuNCT06360068Written as Sulfasalazine Tablets
- Sulfasalazine in Patients With Metastatic Colorectal CancerRecruitingPhase 3Tanta UniversityNCT06134388Written as Sulfasalazine
- Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic ArthritisRecruitingPhase 3University of Erlangen-Nürnberg Medical SchoolNCT04610476Written as Sulfasalazine
- Sulfasalazine for the Treatment of Primary Sclerosing CholangitisCompletedPhase 2Brigham and Women's HospitalNCT03561584Written as Sulfasalazine
- Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer PatientsCompletedPhase 2University of ArizonaNCT03847311Written as Sulfasalazine
- Drug-drug Interaction Study with GLPG3970 and Sulfasalazine in Adult, Healthy SubjectsCompletedPhase 1Galapagos NVNCT04720183Written as Sulfasalazine
- Topical Sulfasalazine and Oral Lichen PlanusActive, not recruitingPhase 3Cairo UniversityNCT06060301Written as sulfasalazine 500 MG
- IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIACompletedPhase 4University of Illinois at ChicagoNCT02451748Written as Sulfasalazine
- Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid ArthritisCompletedPhase 3University of NebraskaNCT00579878Written as Methotrexate-Sulfasalazine-Hydroxychloroquine
- Sulfasalazine and Stereotactic Radiosurgery for Recurrent GlioblastomaCompletedPhase 1Haukeland University HospitalNCT04205357Written as Sulfasalazine
- A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of SulfasalazineCompletedPhase 1Bristol-Myers SquibbNCT05445440Written as Sulfasalazine
- Treatments Against RA and Effect on FDG-PET/CTCompletedPhase 4Brigham and Women's HospitalNCT02374021Written as Sulfasalazine
- A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677CompletedPhase 1CelgeneNCT04268394Written as Sulfasalazine
- Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate MonotherapyTerminatedPhase 3Jawaharlal Institute of Postgraduate Medical Education & ResearchNCT02930343Written as Sulfasalazine
See all 37 studies that test Sulfasalazine →
Given in every arm · 12 — Sulfasalazine is usual care beside what is tested
- Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED TrialCompletedPhase 4University of OxfordNCT03739853Written as Sulfasalazine
- Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid ArthritisCompletedPhase 4SanofiNCT03449758Written as Sulfasalazine
- Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDsStatus unknownPhase 4Nanfang Hospital, Southern Medical UniversityNCT04077957Written as Sulfasalazine
- A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid ArthritisCompletedPhase 3Hoffmann-La RocheNCT01941095Written as Sulfasalazine
- A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)CompletedPhase 3SanofiNCT02373202Written as Sulfasalazine
- To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)CompletedPhase 3SanofiNCT01709578Written as sulfasalazine
- To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)CompletedPhase 3SanofiNCT01768572Written as sulfasalazine
- To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid ArthritisCompletedPhase 3SanofiNCT02057250Written as Sulfasalazine
- Oral Pharmacokinetics of Sulfasalazine, Paracetamol, Fexofenadine and Valsartan Using Different Administration MediumsCompletedPhase 1University Medicine GreifswaldNCT03012763Written as Sulfasalazine
- Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy SubjectsCompletedPhase 1University Medicine GreifswaldNCT01596777Written as Sulfasalazine
- Dose Reduction of Etanercept in Patients With Ankylosing SpondylitisStatus unknownPhase 4Zhixiang HuangNCT02638896Written as Sulfasalazine
- Effects of Methylnaltrexone in Comparison to Naloxone on Loperamide-induced Delay of the Oro-cecal, Whole-gut and Colon Transit Time.CompletedPhase 1University Medicine GreifswaldNCT01596764Written as Sulfasalazine
As the comparator · 5 — what is tested is compared with Sulfasalazine
- Methotrexate, Blood Pressure and Arterial Function in Rheumatoid ArthritisCompletedPhase 4Flinders UniversityNCT03254589Written as Sulfasalazine
- Psoriatic Oligoarthritis Intervention With Symptomatic thErapyCompletedPhase 4University of OxfordNCT03797872Written as Sulfasalazine
- Very Early Versus Delayed Etanercept in Patients With RACompletedPhase 4University of LeedsNCT02433184Written as Sulfasalazine
- Targeted Treatment Early With Etanercept + Methotrexate vs.T2T Care for DMARD-naïve Early RA Patients Based on naïve T-cell StratificationStatus unknownPhase 4University of LeedsNCT03813771Written as Sulfasalazine
- Study Evaluating Etanercept and Sulphasalazine in Ankylosing SpondylitisCompletedPhase 4Wyeth is now a wholly owned subsidiary of PfizerNCT00247962Written as sulphasalazine (SSZ)
Codes
What other systems call Sulfasalazine · ClinicalTrials.gg INT008175
- MeSH (NLM) D012460SulfasalazineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 3XC8GUZ6CBSULFASALAZINEConfirmed FDA, NLM, Wikidata
- RxNorm 9524Confirmed FDA, Wikidata
- Wikidata Q420035sulfasalazineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29469SulfasalazineOne source FDA
- DrugBank DB00795One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D012460 | Sulfasalazine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 3XC8GUZ6CB | SULFASALAZINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 9524 | — | Confirmed FDA, Wikidata |
| Wikidata | Q420035 | sulfasalazine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29469 | Sulfasalazine | One source FDA |
| DrugBank | DB00795 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.